home / stock / cort / cort articles

CORT Articles, Corcept Therapeutics Incorporated

Stock Information
Company Name: Corcept Therapeutics Incorporated
Stock Symbol: CORT
Market: NASDAQ
Website: corcept.com
Menu
CORT CORT Quote CORT Short CORT News CORT Articles CORT Message Board
Get CORT Alerts

News, Short Squeeze, Breakout and More Instantly...
Zevra Rises on Update on Niemann-Pick Disease Type C Drug | Benzinga

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) announced that the FDA has indicated that it will convene a meeting with the recently formed Genetic Metabo...
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions | Benzinga

Results from the CATALYST clinical trial were presented at the American Diabetes Association's 84th Scientific Sessions at a featured plenar...

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome) | Benzinga

MENLO PARK, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the...
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling more than 100 points on Tuesday. Shares of NVIDIA Corporation (NASDAQ:NVDA) rose during Tu...

Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday? | Benzinga

Tuesday, Corcept Therapeutics Incorporated (NASDAQ:CORT) announced that the GRACE Phase 3 trial of relacorilant in patients wit...

LEONARD BAKER JR Makes A Tactical Move: Adds Corcept Therapeutics Stock Options To Portfolio | Benzinga

In a new SEC filing on May 21, it was unveiled that JR, Director at Corcept Therapeutics (NASDAQ:CORT), acquired stock options for 30,000 shares. W...
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call | Benzinga

MENLO PARK, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report first quar...

Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter | Benzinga

Monday, Corcept Therapeutics Incorporated (NASDAQ:CORT) released results from the open-label portion of the pivotal Phase 3 GRACE trial o...

What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday? | Benzinga

Thursday, Corcept Therapeutics Incorporated (NASDAQ:CORT) released announced preliminary results from the prevalence phase of its ongoing...
Next 10